SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001213900-21-044387
Filing Date
2021-08-23
Accepted
2021-08-23 17:12:25
Documents
11

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1819833
2 GRAPHIC image_001.jpg GRAPHIC 5954
3 GRAPHIC image_002.jpg GRAPHIC 44918
4 GRAPHIC image_003.jpg GRAPHIC 46430
5 GRAPHIC image_004.jpg GRAPHIC 29609
6 GRAPHIC image_005.jpg GRAPHIC 33048
7 GRAPHIC image_006.jpg GRAPHIC 38536
8 GRAPHIC image_007.jpg GRAPHIC 30358
9 GRAPHIC image_008.jpg GRAPHIC 29116
10 GRAPHIC image_009.jpg GRAPHIC 27196
11 GRAPHIC image_010.jpg GRAPHIC 43581
  Complete submission text file 0001213900-21-044387.txt   2274871
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: DRS | Act: 33 | File No.: 377-05402 | Film No.: 211197676
SIC: 2836 Biological Products, (No Diagnostic Substances)